Carbapenems & Monobactams - The Big Guns
- Carbapenems (-penem): Broad-spectrum β-lactams, often reserved for multidrug-resistant (MDR) organisms (e.g., ESBL+ bacteria).
- MOA: Inhibit cell wall synthesis via penicillin-binding proteins (PBPs).
- Agents: Imipenem, Meropenem, Ertapenem, Doripenem.
- Adverse: GI distress, rash, CNS toxicity (seizures, esp. Imipenem).
- 💡 Imipenem is always co-administered with Cilastatin (a renal dehydropeptidase I inhibitor) to prevent its degradation.
- Monobactams (Aztreonam):
- Spectrum: Narrow; aerobic Gram-negative rods ONLY (including Pseudomonas).
⭐ Aztreonam has no cross-allergenicity with penicillins/cephalosporins, making it safe for most penicillin-allergic patients.

The Carbapenems - 'Penem Powerhouses
Potent, broad-spectrum β-lactam antibiotics often reserved for severe or multidrug-resistant (MDR) infections. They are bactericidal, inhibiting cell wall synthesis by binding to penicillin-binding proteins (PBPs). Their structure makes them highly resistant to most β-lactamases, including ESBLs.
| Drug | Gram (+) | Gram (-) | Anaerobes | Pseudomonas | Key Features & Adverse Effects |
|---|---|---|---|---|---|
| Imipenem | ✅ | ✅ | ✅ | ✅ | Must be given with Cilastatin (a dehydropeptidase I inhibitor) to prevent renal inactivation. Highest risk of seizures. |
| Meropenem | ✅ | ✅ | ✅ | ✅ | Stable to dehydropeptidase I. Lower seizure risk than imipenem. |
| Ertapenem | ✅ | ✅ | ✅ | ❌ | The exception: Lacks coverage for Pseudomonas, Acinetobacter, Enterococcus (📌 APE). Convenient once-daily dosing. |
| Doripenem | ✅ | ✅ | ✅ | ✅ | Generally has greater activity against Pseudomonas and is more stable in solution. |
Imipenem-Cilastatin - The Kidney Guard
- Imipenem: A broad-spectrum carbapenem antibiotic.
- Cilastatin: A renal dehydropeptidase I inhibitor; acts as a "bodyguard."
- Synergy: Cilastatin prevents renal metabolism of Imipenem, increasing its half-life and protecting against nephrotoxic metabolites.
- ⚠️ Adverse Effects: CNS toxicity (confusion, myoclonus, seizures), especially in patients with renal insufficiency.
⭐ Imipenem is often nicknamed "seizure-penem." The risk is heightened when co-administered with ganciclovir.
Aztreonam - The Lone Ranger
- Class: Monobactam; structurally distinct from other β-lactams.
- Mechanism: Binds exclusively to Penicillin-Binding Protein 3 (PBP-3) of Gram-negative aerobes, preventing peptidoglycan cross-linking and inhibiting cell wall synthesis.
- Spectrum: Narrow. Active ONLY against aerobic Gram-negative rods, including Pseudomonas aeruginosa.
- Key Use: Safe alternative for patients with a history of severe, IgE-mediated penicillin allergy.
⭐ Minimal cross-allergenicity with other β-lactams, with the notable exception of ceftazidime due to a similar R-group side chain.
High‑Yield Points - ⚡ Biggest Takeaways
- Carbapenems are broad-spectrum β-lactamase-resistant drugs for multidrug-resistant organisms.
- Imipenem is always given with cilastatin, which blocks its inactivation by renal dehydropeptidase I.
- A major adverse effect of carbapenems is CNS toxicity, which can lower the seizure threshold.
- Aztreonam, a monobactam, has a narrow spectrum limited to aerobic gram-negative rods.
- Aztreonam has no cross-allergenicity with penicillins, making it safe for allergic patients.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more